Clinical Trials Directory

Trials / Completed

CompletedNCT01275885

Vitamin D Intervention in Infants - Pilot

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
113 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aims of the present study are to evaluate the concentrations of vitamin D in the plasma and of calcium in the plasma and in the urine as well as to evaluate bone mineral density using peripheral quantitative computed tomography (pQCT), after supplementation of vitamin D with 30µg (1200 IU) and 40µg (1600 IU), in comparison with currently recommended supplementation of vitamin D with 10µg (400 IU). In this pilot study supplementation is given to infants from 2 weeks of age to 3 months of age.

Detailed description

Vitamin D deficiency is common around the world. In Finland vitamin D levels are low in all age groups. Especially infants are predisposed to vitamin D deficiency. Partly this is due to low exposure to sunlight but mainly it is due to low dietary intake of vitamin D. Vitamin D prophylaxis was introduced in Finland in the 1950´s to overcome rickets. However, the recommended dose has decreased from 50µg (2000 IU) in the 1960´s to 10µg (400 IU) from beginning of the 1990´s. The serum concentration of 25-hydroxyvitamin D (S-25OHD) is used as a marker of vitamin D status in the body. Although there is no consensus of optimal concentration of S-25OHD, it has been proposed that concentrations lower than 50 nmol/l indicate deficiency. According to recent findings on 25-OHD concentrations in Finnish children, currently recommended intake of vitamin D is inadequate.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcholecalciferol (D3)10µg (400 IU) orally daily for 10 weeks
DIETARY_SUPPLEMENTcholecalciferol (D3)30µg (1200 IU) orally daily for 10 weeks
DIETARY_SUPPLEMENTcholecalciferol (D3)40µg (1600 IU) orally daily for 10 weeks

Timeline

Start date
2010-08-01
Primary completion
2011-05-01
Completion
2011-06-01
First posted
2011-01-13
Last updated
2011-07-18

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01275885. Inclusion in this directory is not an endorsement.